Andy Muray: Meconium's case was fully Awkwardness


Britain's Andy Murray, feeling the strangeness because there are a lot of the world's top athletes who tested positive for meldonium in the last two months.

Meldonium declared a prohibited substance by the World Anti-Doping Agency (Wada) since January 1, 2016, because after passing the scrutiny of the year, the drug shown to improve performance.

Former world number one tennis player, Maria Sharapova, on Monday (7/3) night made a surprise confession himself declared the International Tennis Federation uses meldonium at the Australian Open. Russian athletes have subsequently admitted that he was taking the pill sold under the commercial name Mildronate since 2006 for health reasons.

Sharapova is not the first athlete to fail a doping test because otherwise meldonium.

Another athlete who tested positive was Abeba Aregawi, a Swedish runner who won the 1500 meter run numbers at the World Championship 2013. In addition, ice skating athlete Ekaterina Bobrova also announced that he was positive meldonium at the European Ice Skating Championships in 2016.

"I think as of 1 January there are 55 different athletes who failed doping tests because meldonium," Murray told BBC Radio 5 Live.

"I think a little strange that there are drugs used for heart disease, and there are a lot of athletes competing at the highest level have the disease. It's a little awkward."

Murray asked that tennis organizations do more action to combat doping.

"Last year I was often tested. But this year has been running for three months, I've been tested twice. This is obviously not enough," said Murray.

Collectors of two Grand Slam titles and asked Sharapova received a sentence for assault using doping.

"Of course, when you use a drug that can improve performance and also when you fail a doping test, then you must be punished," said Murray.
Andy Muray: Meconium's case was fully Awkwardness Andy Muray: Meconium's case was fully Awkwardness Reviewed by Unknown on March 11, 2016 Rating: 5

1 comment:

Powered by Blogger.